Real-time insider trades Start Free
Profitelligence
Hims & Hers Health, Inc.
HIMS

Hims & Hers Health, Inc.

Okupe Oluyemi Files Hims & Hers Health (HIMS) Form 4 - December 15, 2025

| Form 4 |Consumer Defensive

Transactions

Insider Date Type Shares Price Value Own
Okupe Oluyemi 2025-12-15 Sell 11.5K $0.00 $0.00 Direct
Okupe Oluyemi 2025-12-15 Sell 52.4K $0.00 $0.00 Direct
Okupe Oluyemi 2025-12-15 Sell 58.0K $36.25 $2.1M Direct
Okupe Oluyemi 2025-12-15 Buy 105.2K - $0.00 Direct
Okupe Oluyemi 2025-12-15 Sell 23.0K $0.00 $0.00 Direct
Okupe Oluyemi 2025-12-15 Sell 18.3K $0.00 $0.00 Direct
Profitelligence Profitelligence Alerts

Track HIMS insider activity

Get alerts when Hims & Hers Health, Inc. executives trade their shares.

Set Up Alerts →

Advertisement

About Hims & Hers Health, Inc.

Hims & Hers Health, Inc. is a telehealth service provider that aims to simplify and enhance healthcare access for consumers. The company specializes in personal care and wellness products and services, offering both prescription and over-the-counter solutions. With a focus on destigmatizing health and wellness issues, Hims & Hers addresses areas such as dermatology, sexual health, hair care, and mental wellness, appealing to a broad demographic looking for convenient and private healthcare options. By facilitating online consultations with licensed medical professionals, the company allows users to receive medical advice, treatments, and prescriptions, all accessible from the comfort of their homes. Hims & Hers plays a significant role in the growing digital healthcare market, leveraging technology to provide more accessible and personalized healthcare experiences. Headquartered in San Francisco, the company capitalizes on the increase in demand for telehealth services, buoyed by advancements in digital health trends and the expanding e-commerce space for healthcare solutions.

Exchange: NYSE Industry: Household & Personal Products Company Website

Official SEC Documents

HIMS
HIMS Research
Insider trades, 8Ks, financials, technicals
Form 4 Insider Tracker
See what executives are buying and selling

Advertisement